Matthew L. Sherman, EVP & Chief Medical Officer at ACCELERON PHARMA INC (XLRN), sold 2,000 shares at $27.62 ($55K) on 2017-01-04, disclosed to the SEC on 2017-01-06.
Scheduled sale ($55k) by EVP & Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.81 | 400 | $11K | 19.5% |
| 2 | $27.62 | 1,600 | $44K | 80.5% |
| Total | $27.46 avg | 2,000 | $55K | 100% |
| Filing → |
| DCPH | SELL | 2023-12-14 | $43K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $28K | — | Filing → |
| DCPH | SELL | 2023-10-04 | $37K | — | Filing → |